Schedule 13G ownership disclosure

Aura Biosciences Inc

Common Stock · CUSIP: 05153U107

Event date: 2024-12-24

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • LONG FOCUS CAPITAL MANAGEMENT, LLC

    Shares: 2,507,774.00 · Class: 3.6%

  • LONG FOCUS CAPITAL MASTER, LTD.

    Shares: 1,782,997.00 · Class: 3.6%

  • CONDAGUA, LLC

    Shares: 724,777.00 · Class: 1.4%

  • JOHN HELMERS

    Shares: 2,507,774.00 · Class: 5.7%

  • GLENN HELMERS

    Shares: 724,777.00 · Class: 1.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001019056-25-000005
Form type
SCHEDULE 13G
Filer
Aura Biosciences, Inc.
CIK
CIK 1501796
Filed
Jan 03, 2025
Reporting period
Dec 24, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub